[Kinetics of beta-lactamase inhibition by clavulanic acid]
- PMID: 363163
- DOI: 10.1016/0005-2744(78)90147-x
[Kinetics of beta-lactamase inhibition by clavulanic acid]
Abstract
The mechanisms of action of 3 R-factors on beta-lactamases (penicillin amido-beta-lactamhydrolase, EC 3.5.2.6) (TEM-1 pI = 5.4, TEM-2 pI = 5.6 and Pitton's type 2 pI = 7.7) have been kinetically analyzed for clavulanic acid inactivation. Clavulanic acid appears as a competitive and irreversible inhibitor (Kcat inhibitor) reacting in two steps: a, formation of a reversible enzyme . inhibitor complex (characterized by a Ki); b, evolution of the reversible complex into a new derivative (covalent, stable and inactive) by monomolecular kinetics characterized by a k6 (or Kcat) related to half-life. The kinetic constants are: TEM-1: Ki = 0.8 micrometer, k6 = 0.027 s-1; TEM-2: Ki = 0.7 micrometer, k6 = 0.03 s-1; type 2: Ki = 0.6 micrometer, k6 = 0.046 s-1. These results justify the 'progressive irreversible' character of the inhibition generally described.
Similar articles
-
Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).Biochim Biophys Acta. 1980 Feb 14;611(2):351-7. doi: 10.1016/0005-2744(80)90071-6. Biochim Biophys Acta. 1980. PMID: 6243991
-
Clavulanic acid inhibition of beta-lactamase I from Bacillus cereus 569/H.J Antibiot (Tokyo). 1978 Nov;31(11):1162-9. doi: 10.7164/antibiotics.31.1162. J Antibiot (Tokyo). 1978. PMID: 102630
-
Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.FEMS Microbiol Lett. 2002 May 21;211(1):13-6. doi: 10.1111/j.1574-6968.2002.tb11196.x. FEMS Microbiol Lett. 2002. PMID: 12052544
-
Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.J Antimicrob Chemother. 1999 Apr;43(4):447-58. doi: 10.1093/jac/43.4.447. J Antimicrob Chemother. 1999. PMID: 10350372 Review.
-
Progress toward inhibitors of metallo-β-lactamases.Future Med Chem. 2017 May;9(7):673-691. doi: 10.4155/fmc-2017-0007. Epub 2017 May 15. Future Med Chem. 2017. PMID: 28504895 Review.
Cited by
-
Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin.Antimicrob Agents Chemother. 1981 Dec;20(6):800-2. doi: 10.1128/AAC.20.6.800. Antimicrob Agents Chemother. 1981. PMID: 7034642 Free PMC article. Clinical Trial.
-
Kinetic studies on the inhibition of Proteus vulgaris beta-lactamase by imipenem.Antimicrob Agents Chemother. 1984 Jan;25(1):149-51. doi: 10.1128/AAC.25.1.149. Antimicrob Agents Chemother. 1984. PMID: 6367634 Free PMC article.
-
Activities of amoxicillin and clavulanic acid combinations against urinary tract infections.Antimicrob Agents Chemother. 1982 Aug;22(2):346-9. doi: 10.1128/AAC.22.2.346. Antimicrob Agents Chemother. 1982. PMID: 6765418 Free PMC article. Clinical Trial.
-
Kinetics of inactivation of beta-lactamase I by 6 beta-bromopenicillanic acid.Biochem J. 1980 Jun 1;187(3):797-802. doi: 10.1042/bj1870797. Biochem J. 1980. PMID: 6331385 Free PMC article.
-
Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39.Biochem J. 1982 Dec 1;207(3):429-36. doi: 10.1042/bj2070429. Biochem J. 1982. PMID: 6984651 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous